Abstract
We use CRT (Cardiac Resynchronization Therapy) to treat dyssynchrony and heart failure. However, 30-40% of patients do not respond to the current method. For these patients may solution be a new wireless endocardial CRT pacing. Power is supplied wirelessly via a subcutaneous ultrasound pulse generator. WiSE-CRT therapy offers many advantages, including the ability to provide local stimulation and targeted stimulation without regard to the implantation site in the left ventricle. Other benefits that were noted during treatment include QRS shorter duration, an increase in ejection fraction, and no need for treatment with anticoagulants. In addition, patients do not suffer from endocarditis associated with conventionally CRT. The efficacy of WiSE-CRT is tested, as it has already been positively evaluated in Europe.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
